APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

Current Biology

Volumn 14, Issue 15, 2004, Pages 1385-1391

  Liddament, Mark T ^a   Brown, William L ^a   Schumacher, April J ^a   Harris, Reuben S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; APOBEC3F PROTEIN, HUMAN; CEM15 PROTEIN, HUMAN; CYTOSINE DEAMINASE; DEAMINASE; PRIMER DNA; PROTEIN; REPRESSOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POINT MUTATION; REGULATOR GENE; SEQUENCE ALIGNMENT; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BASE SEQUENCE; BLOTTING, NORTHERN; CYTOSINE DEAMINASE; DNA PRIMERS; GENES, VIF; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NUCLEOSIDE DEAMINASES; POINT MUTATION; PROTEINS; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4143071549     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.06.050     Document Type: Article

References (35)

1. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 418:2002;646-650
2. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell. 113:2003;803-809
3. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 424:2003;94-98
4. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 424:2003;99-103
5. Lecossier D., Bouchonnet F., Clavel F., Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 300:2003;1112
6. Yu Q., Konig R., Pillai S., Chiles K., Kearney M., Palmer S., Richman D., Coffin J.M., Landau N.R. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11:2004;435-442
7. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 114:2003;21-31
8. Shindo K., Takaori-Kondo A., Kobayashi M., Abudu A., Fukunaga K., Uchiyama T. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J. Biol. Chem. 278:2003;44412-44416
9. Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., Neuberger M.S. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes. correlation with mutation spectra in vivo J. Mol. Biol. 337:2004;585-596
10. Janini M., Rogers M., Birx D.R., McCutchan F.E. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J. Virol. 75:2001;7973-7986
11. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 79:2002;285-296
12. Navaratnam N., Fujino T., Bayliss J., Jarmuz A., How A., Richardson N., Somasekaram A., Bhattacharya S., Carter C., Scott J. Escherichia coli cytidine deaminase provides a molecular model for apoB RNA editing and a mechanism for RNA substrate recognition. J. Mol. Biol. 275:1998;695-714
13. Turelli P., Mangeat B., Jost S., Vianin S., Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science. 303:2004;1829
14. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 418:2002;99-103
15. Pham P., Bransteitter R., Petruska J., Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature. 424:2003;103-107
16. Yu K., Huang F.T., Lieber M.R. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279:2004;6496-6500
17. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell. 10:2002;1247-1253
18. Conticello S.G., Harris R.S., Neuberger M.S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13:2003;2009-2013
19. Marin M., Rose K.M., Kozak S.L., Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:2003;1398-1403
20. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:2003;1404-1407
21. Stopak K., de Noronha C., Yonemoto W., Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell. 12:2003;591-601
22. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 302:2003;1056-1060
23. Bogerd H.P., Doehle B.P., Wiegand H.L., Cullen B.R. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA. 101:2004;3770-3774
24. Mangeat B., Turelli P., Liao S., Trono D. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279:2004;14481-14483
25. Schrofelbauer B., Chen D., Landau N.R. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA. 101:2004;3927-3932
26. Xu H., Svarovskaia E.S., Barr R., Zhang Y., Khan M.A., Strebel K., Pathak V.K. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA. 101:2004;5652-5657
27. Wiegand H.L., Doehle B.P., Bogerd H.P., Cullen B.R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23:2004;2451-2458. 10.1038/sj.emboj.7600246
28. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78:2004;6073-6076
29. Li Y., Kappes J.C., Conway J.A., Price R.W., Shaw G.M., Hahn B.H. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue. identification of replication-competent and -defective viral genomes J. Virol. 65:1991;3973-3985
30. Vartanian J.P., Henry M., Wain-Hobson S. Sustained G→A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83:2002;801-805
31. Fitzgibbon J.E., Mazar S., Dubin D.T. A new type of G→A hypermutation affecting human immunodeficiency virus. AIDS Res. Hum. Retroviruses. 9:1993;833-838
32. Charneau P., Borman A.M., Quillent C., Guetard D., Chamaret S., Cohen J., Remy G., Montagnier L., Clavel F. Isolation and envelope sequence of a highly divergent HIV-1 isolate. definition of a new HIV-1 group Virology. 205:1994;247-253
33. Yu, Q., Konig, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J.M., and Landau, N.R. (2004). Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct Mol. Biol. 11, 435-442. 10.1038/nsmb758
34. Vartanian J.P., Sommer P., Wain-Hobson S. Death and the retrovirus. Trends Mol. Med. 9:2003;409-413
35. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.-J., Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14:2004;1392-1396., this issue. Published online June 24, 2004. 10.1016/S0960982204004683